ACET
Adicet Bio, Inc.
Key Financials
Operating Income
$-122114000
↑ 4.3%
Net Income
$-116803000
↑ 0.3%
Total Assets
$192.4M
↓ 12.7%
Total Liabilities
$33.1M
↓ 1.4%
Shareholders' Equity
$159.2M
↓ 14.7%
EPS (Diluted)
$-16.95
↓ 1174.4%
Operating Cash Flow
$-95246000.00
↓ 3.1%
Dividends/Share
$0.00
NaN%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 4/13/2026 | View on SEC |
| 4 | 4/13/2026 | View on SEC |
| 3 | 4/13/2026 | View on SEC |
| SCHEDULE 13D/A | 4/10/2026 | View on SEC |
| 4 | 4/9/2026 | View on SEC |
| 144 | 4/9/2026 | View on SEC |
| 144 | 4/8/2026 | View on SEC |
| 144 | 4/7/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACET |
| Company Name | Adicet Bio, Inc. |
| CIK | 1720580 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1226 |
| State of Incorporation | DE |
| Phone | 617-482-2333 |